A survey of oncologists/fertility specialists suggests that cancer patients in Europe could be missing out on options to preserve fertility due to lack of awareness.
Browsing: clinical guidelines
Leading experts devise new guidelines to score thyroid nodules and avoid unnecessary surgery and aspiration numbers for benign nodules.
This report outlines the clinically led development of UK-focused guidance to challenge psycho-oncology services to achieve and demonstrate their potential.
Armed with over 10 years of positive EU experience, a significant logical and well-founded evolution is underway with biosimilar medicines offering great benefits for all involved in the healthcare system. Julie Maréchal-Jamil from Biosimilar Medicines group (a Medicines for Europe sector group) explains.
Skin cancer screening: recommendations for data-driven screening guidelines & a review of the US Preventative Services Task Force controversy
In this review article, over 50 leaders in the dermatology field critically assess current screening practice for melanoma in an effort to propose rational, risk-based, data-driven guidelines for skin cancer screening.
Management of the adverse events of afatinib: a consensus of the recommendations of the Spanish expert panel
This article provides recommendations for the prophylaxis and treatment of side effects associated with the use of Afatinib for the treatment of EGFR M+ non-small cell lung cancer.
A perspective piece discusses prostate cancer screening guidance for primary care providers, highlighting the importance of including patients in screening decisions.
Increased colorectal cancer screening rates observed post-2008 in individuals of lower socioeconomic status may be the effect of the Affordable Care Act reducing the financial burden of such activities.
Factors affecting the adoption and use of gene expression profiling by oncologists in clinical practice
This research article investigates the adoption of gene expression profiling by oncologists who treat breast cancer patients in informing treatment recommendations.
Researchers from the University of Kansas Medical Center have found that compliance with post-treatment surveillance, income level and travel distance for follow-up care were all associated with survival in patients with head and neck squamous cell cancer.